A comparative study of cisplatin-based definitive chemo-radiation in non-metastatic squamous cell carcinoma of the esophagus
Introduction: Esophageal cancer is the seventh most frequent malignancy in Iranian men and the fourth most common cancer in Iranian women. It is also among the 10 most frequent cancers in the world. Definitive chemoradiation using cisplatin with 5-fluorouracil (5-FU) is known as the standard of ca...
Main Authors: | Bahram Mofid, Abolfazl Razzaghdoust, Amir Shahram Yousefi Kashi, Hamid Reza Mirzaei |
---|---|
Format: | Article |
Language: | English |
Published: |
Electronic Physician
2016-10-01
|
Series: | Electronic Physician |
Subjects: | |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133030/ |
Similar Items
-
Comparison of survival and adverse effect profile in patients with esophageal cancer treated with the combination of carboplatin and paclitaxel vs. 5-flourouracil and cisplatin
by: N. Nisar, et al.
Published: (2022-09-01) -
Current Development of Anti-Cancer Drug S-1
by: Pratima Chhetri, et al.
Published: (2016-11-01) -
Efficacy of cisplatin-based combinations in chemoradiation therapy of cervical cancer
by: I Ya Bazaeva, et al.
Published: (2015-09-01) -
Randomized Phase II Study with Cetuximab in Combination with 5-FU and Cisplatin or Carboplatin Vs. Cetuximab in Combination with Paclitaxel and Carboplatin for Treatment of Patients with Relapsed or Metastatic Squamous Cell Carcinoma of the Head and Neck (CETMET Trial)
by: Georgios Tsakonas, et al.
Published: (2020-10-01) -
Comparison of definite chemoradiation therapy with carboplatin/paclitaxel or cisplatin/5-fluoruracil in patients with squamous cell carcinoma of the esophagus
by: Stefan Münch, et al.
Published: (2018-08-01)